HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Barnaby Pickering

Reporter, Medtech Insight

London, UK

Graduating in 2020 with a Master’s degree in biomedical engineering from University College London, Barnaby is passionate about all things medtech. In his first role as a journalist, Barnaby will focus on R&D and commercial stories in medtech, and writing about emerging technologies such as digital health, artificial intelligence, machine learning, deep-brain implants, and nanoscale applications of medtech. Alongside this, Barnaby is looking forward to taking deeper dives into start-ups, device market analysis, and company financial data, to create informed, useful, and engaging content.

Barnaby lives in in rural Wiltshire, UK and is a keen reader, cyclist, and hobbyist jeweler.

Latest From Barnaby Pickering

Minute Insight: Agendia Collaborates With Illumina And Brazilian Health Care Providers

The company expects the major commercial collaboration and geographical roll-out will lead to increased adoption of Agendia’s breast cancer diagnostics.

Minute Insights In Vitro Diagnostics

JPM 2022 Mid-Week IVD Roundup: Guardant, Illumina, Ortho Clinical, Thermo Fisher

The annual J.P. Morgan Healthcare Conference includes presentations from major medtech companies describing their experience in 2021 and expectations for 2022. Here are some highlights from the in vitro diagnostics companies that presented on the first two days of the meeting.

In Vitro Diagnostics Diagnostics

Interview: What Does Breakthrough Designation Mean For Manus Neurodynamica?

Medtech Insight spoke to Rutger Zietsma, Manus Neurodynamica’ CEO, to learn about the next commercial steps for the company's Neuromotor Pen for differential diagnosis of neuromotor impairment.

Diagnostics Neurology

MeMed Secures $93M Financing To Commercialize Diagnostics Platform

The company will use the money to fund its US commercialization strategy and continue to develop its host response-based product pipeline.

Diagnostics Financing

Blue Sky Thinking: CEOs, Analysts Offer Some Thoughts On 2022

As Omicron further destabilizes the medtech space, potentially mirroring the spring of 2020, some executives shared with Medtech Insight their views on what will hopefully be a bumper year for the sector.

Coronavirus COVID-19 Innovation

Money And Materials Will Allow Medtech To Restore Lost Neuro Functions

Medtech Insight spoke to the CEOs Blackrock Neurotech, and Pixium Vision, to find out how their devices can restore lost neurological function, and how devices that interface with the brain may shape the future of medicine.

Neurology Clinical Trials
See All
UsernamePublicRestriction

Register